Get to clinic faster with a simplified formulation strategy

Quickly achieve your first-in-human milestone with a simplified drug product formulation strategy.

Formulation development underpinned by biopharmaceutics & clinical knowledge

Quotient Sciences has more than 30 years of experience developing a breadth of formulations for small molecules and peptides, across a range of indications. With expertise in simple and complex dosage forms, we have formulated over 1,500 molecules. 

Want to know more about our formulation capabilities?

Download Info Sheet

Supporting a U.S. Biotech with DCS classification and product development of an NCE to rapidly achieve first-in-human

When a U.S. Biotech company wanted to determine the DCS (Developability Classification System) designation for their small molecule, they approached Quotient Sciences for a tailored formulation development program to quickly go from preclinical to first-in-human.

Continue reading the results of the program.

Download Case Study

Discuss your program with us today

Learn more about Quotient Sciences' services

See how we can help you with your next drug program.

Early Clinical Development
Integrated first-in-human and clinical pharmacology programs that help you make critical decisions earlier.
Discover More
Drug Product Development & Manufacturing
Experienced formulation development, clinical manufacturing, and sustained commercial production of your product.
Explore Service
Translational Pharmaceutics® Integrated Drug Development
Our unique approach to drug development, integrating clinical activities with real-time cGMP drug product manufacturing.
Discover More
Case Studies
Discover how we've helped pharma and biotech organizations successfully meet their milestones.
See Examples